Marc Puyraveau

InstitutionuMETh-INSERM CIC 431Besançon
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in August 2020 and June 2021 and July 2021
    All Publications
    Bar chart showing 62 publications over 19 distinct years, with a maximum of 8 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Timothée K, Gerazime A, Puyraveau M, Kadiane-Oussou NJ, Gendrin V, Zayet S. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562. PMID: 34036334.
      Citations:    Fields:    
    2. Klopfenstein T, Gendrin V, Gerazime A, Conrozier T, Balblanc JC, Royer PY, Lohse A, Mezher C, Toko L, Guillochon C, Badie J, Pierron A, Kadiane-Oussou N'J, Puyraveau M, Zayet S. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia. Infect Dis Ther. 2021 Sep; 10(3):1195-1213. PMID: 34247325.
      Citations: 3     
    3. Klopfenstein T, Gendrin V, Conrozier T, Gerazime A, Puyraveau M, Zayet S. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann Rheum Dis. 2021 Jun 23. PMID: 34162593.
      Citations:    Fields:    
    4. Falcoz PE, Monnier A, Puyraveau M, Perrier S, Ludes PO, Olland A, Mertes PM, Schneider F, Helms J, Meziani F. Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort? Am J Respir Crit Care Med. 2020 08 01; 202(3):460-463. PMID: 32543208.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health